Sarah Horton - Concepedia

Author

Sarah Horton

University of Manchester ORCID

Also Known As

Audrey Low, C Gorman, C Murphy, D Roy, James Rees, Josie Goodsell, S Horton, S. HORTON, S. Horton, Sarah E. Horton

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

University of Manchester University College London University of Oxford Manchester Academic Health Science Centre University of Bristol

About

Sarah Horton is an author at University of Manchester specializing in medicine, covid-19, and rheumatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.1K
2	Public Health	3	3	83
3	Epidemiology	3	3	83
4	Allergy	1	1	57
5	Global Health	1	1	48

Sarah Horton

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial Rustam Al‐Shahi Salman, M. J. S. Dennis, PAG Sandercock, The Lancet	2019	188
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19 Simin Florescu, Delia Stanciu, Mihaela Zaharia, JAMA	2022	147
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial Simin Florescu, Delia Stanciu, Mihaela Zaharia, JAMA	2022	133
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2023	126
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19 Zara Izadi, Erica J. Brenner, Satveer K. Mahil, JAMA Network Open	2021	114
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial Rustam Al‐Shahi Salman, David Minks, Dipayan Mitra, The Lancet Neurology	2019	88

Page 1